Highlights Universal Biosensors, Inc.

Equities

UBI

AU000000UBI2

Market Closed - Australian S.E. Other stock markets 05:48:51 01/07/2024 am IST			5-day change	1st Jan Change
0.15 ^AUD	0.00%		+7.14%	-25.00%

30/05	Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call
08/05	Universal Biosensors Raises AU$10 Million via Entitlement Offer	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Universal Biosensors Raises AU$10 Million via Entitlement Offer	08/05	MT
Universal Biosensors Narrows Q1 Loss as Revenue Rises; Shares Fall 3%	02/05	MT
Universal Biosensors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Rights Issue: 100 new shares @ 0.15 AUD for 347 existing shares	15/04	FA
H&G High Conviction Reports Flat Performance for March Quarter	11/04	MT
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%	19/03	MT
Universal Biosensors Narrows 2023 Loss on Absence of Impairment, Higher Revenue; Shares Down 6%	01/03	MT
Universal Biosensors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
Universal Biosensors, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/23/30	CI
Universal Biosensors' Coagulation Analysis Device Gets Approval in Europe	04/23/04	MT
Universal Biosensors Secures Marketing Approval, First Order for Coagulation Analyzer Device in India	31/23/31	MT
Universal Biosensors Secures First Major Tender to Supply Xprecia Prime in Italy	09/23/09	MT
Universal Biosensors Narrows Net Loss 74% in H1	31/23/31	MT
Universal Biosensors, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Universal Biosensors, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/23/31	CI
Universal Biosensors Trims Q1 Loss on Lower Expenses, Absence of Intangible Assets Impairment	11/23/11	MT
Universal Biosensors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
Universal Biosensors Files US FDA Application for Blood Coagulation Testing Device	24/23/24	MT
Universal Biosensors, Inc. Submits Xprecia Prime 510K Application to US Food & Drug Administration	24/23/24	CI
Universal Biosensors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Universal Biosensors, Inc.

Equities

UBI

AU000000UBI2

Highlights

Filters